“Economic Evaluation of Temsirolimus on the Basis of the Results of the ARCC (Advanced Renal-Cell Carcinoma) Study”. Farmeconomia. Health Economics and Therapeutic Pathways 10, no. 2 (June 15, 2009): 93–97. Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/167.